402 related articles for article (PubMed ID: 27974613)
1. A Novel Multisensory Integration Task Reveals Robust Deficits in Rodent Models of Schizophrenia: Converging Evidence for Remediation via Nicotinic Receptor Stimulation of Inhibitory Transmission in the Prefrontal Cortex.
Cloke JM; Nguyen R; Chung BY; Wasserman DI; De Lisio S; Kim JC; Bailey CD; Winters BD
J Neurosci; 2016 Dec; 36(50):12570-12585. PubMed ID: 27974613
[TBL] [Abstract][Full Text] [Related]
2. α₄β₂ Nicotinic receptor stimulation of the GABAergic system within the orbitofrontal cortex ameliorates the severe crossmodal object recognition impairment in ketamine-treated rats: implications for cognitive dysfunction in schizophrenia.
Cloke JM; Winters BD
Neuropharmacology; 2015 Mar; 90():42-52. PubMed ID: 25460188
[TBL] [Abstract][Full Text] [Related]
3. Severe cross-modal object recognition deficits in rats treated sub-chronically with NMDA receptor antagonists are reversed by systemic nicotine: implications for abnormal multisensory integration in schizophrenia.
Jacklin DL; Goel A; Clementino KJ; Hall AW; Talpos JC; Winters BD
Neuropsychopharmacology; 2012 Sep; 37(10):2322-31. PubMed ID: 22669170
[TBL] [Abstract][Full Text] [Related]
4. T-type calcium channels in the orbitofrontal cortex mediate sensory integration as measured using a spontaneous oddity task in rats.
Marks WN; Parker ME; Zabder NK; Greba Q; Snutch TP; Howland JG
Learn Mem; 2018 Jul; 25(7):317-324. PubMed ID: 29907639
[TBL] [Abstract][Full Text] [Related]
5. Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test.
Young JW; Meves JM; Geyer MA
Behav Brain Res; 2013 Mar; 240():119-33. PubMed ID: 23201359
[TBL] [Abstract][Full Text] [Related]
6. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.
Nikiforuk A; Kos T; Hołuj M; Potasiewicz A; Popik P
Neuropharmacology; 2016 Feb; 101():389-400. PubMed ID: 26232639
[TBL] [Abstract][Full Text] [Related]
7. Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.
Lin H; Hsu FC; Baumann BH; Coulter DA; Anderson SA; Lynch DR
Mol Cell Neurosci; 2014 Jul; 61():163-75. PubMed ID: 24983521
[TBL] [Abstract][Full Text] [Related]
8. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
[TBL] [Abstract][Full Text] [Related]
9. Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling.
Parikh V; Ji J; Decker MW; Sarter M
J Neurosci; 2010 Mar; 30(9):3518-30. PubMed ID: 20203212
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms.
Howe WM; Ji J; Parikh V; Williams S; Mocaër E; Trocmé-Thibierge C; Sarter M
Neuropsychopharmacology; 2010 May; 35(6):1391-401. PubMed ID: 20147893
[TBL] [Abstract][Full Text] [Related]
11. Subtype-selective nicotinic acetylcholine receptor agonists can improve cognitive flexibility in an attentional set shifting task.
Wood C; Kohli S; Malcolm E; Allison C; Shoaib M
Neuropharmacology; 2016 Jun; 105():106-113. PubMed ID: 26772970
[TBL] [Abstract][Full Text] [Related]
12. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
[TBL] [Abstract][Full Text] [Related]
13. The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats.
Hajós M; Hurst RS; Hoffmann WE; Krause M; Wall TM; Higdon NR; Groppi VE
J Pharmacol Exp Ther; 2005 Mar; 312(3):1213-22. PubMed ID: 15523001
[TBL] [Abstract][Full Text] [Related]
14. Ketamine administration during the second postnatal week induces enduring schizophrenia-like behavioral symptoms and reduces parvalbumin expression in the medial prefrontal cortex of adult mice.
Jeevakumar V; Driskill C; Paine A; Sobhanian M; Vakil H; Morris B; Ramos J; Kroener S
Behav Brain Res; 2015 Apr; 282():165-75. PubMed ID: 25591475
[TBL] [Abstract][Full Text] [Related]
15. Nicotinic acetylcholine receptor alpha7 and alpha4beta2 subtypes differentially control GABAergic input to CA1 neurons in rat hippocampus.
Alkondon M; Albuquerque EX
J Neurophysiol; 2001 Dec; 86(6):3043-55. PubMed ID: 11731559
[TBL] [Abstract][Full Text] [Related]
16. alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment.
Thomsen MS; Christensen DZ; Hansen HH; Redrobe JP; Mikkelsen JD
Neuropharmacology; 2009; 56(6-7):1001-9. PubMed ID: 19233218
[TBL] [Abstract][Full Text] [Related]
17. The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys.
Cannon CE; Puri V; Vivian JA; Egbertson MS; Eddins D; Uslaner JM
Neuropharmacology; 2013 Jan; 64():191-6. PubMed ID: 22659472
[TBL] [Abstract][Full Text] [Related]
18. 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats.
Potasiewicz A; Hołuj M; Kos T; Popik P; Arias HR; Nikiforuk A
Neuropharmacology; 2017 Feb; 113(Pt A):188-197. PubMed ID: 27717880
[TBL] [Abstract][Full Text] [Related]
19. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
[TBL] [Abstract][Full Text] [Related]
20. Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists.
Radek RJ; Kohlhaas KL; Rueter LE; Mohler EG
Curr Pharm Des; 2010 Jan; 16(3):309-22. PubMed ID: 20109141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
